# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001193125-17-276877
Filing Date
2017-09-05
Accepted
2017-09-05 17:22:05
Documents
7
Effectiveness Date
2017-09-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFR14A | d449670ddefr14a.htm | DEFR14A | 458854
2 | GRAPHIC | g449670g51o28.jpg | GRAPHIC | 6750
3 | GRAPHIC | g449670g68d40.jpg | GRAPHIC | 7348
4 | GRAPHIC | g449670g82l95.jpg | GRAPHIC | 13033
5 | GRAPHIC | g449670page004.jpg | GRAPHIC | 173036
6 | GRAPHIC | g449670page005.jpg | GRAPHIC | 177382
7 | GRAPHIC | g449670page008.jpg | GRAPHIC | 206085
| Complete submission text file | 0001193125-17-276877.txt |  | 1264146

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: DEFR14A | Act: 34 | File No.: 000-17988 | Film No.: 171069597
SIC: 2835 In Vitro & In Vivo Diagnostic Substances